1. Home
  2. Health
  3. Rare Diseases
Rare Diseases Blog

From Mary Kugler, R.N., Former About.com Guide to Rare Diseases

Possible targets for a multiple myeloma vaccine

Thursday April 28, 2005
Joint research conducted by the Weill Medical College of Cornell University and the Ludwig Institute for Cancer Research in New York has identified two proteins, CT7 and MAGE-A3/6, in human myeloma cells responsible for multiple myeloma, a blood cancer. The researchers believe these proteins may be ideal targets for a multiple myeloma vaccine. Studies are underway to see if immune cells of people with the disease can recognize and attack cells that have either CT7 or MAGE-A3/6. The protein research was published in the March 2005 online edition of Blood.

Comments

No comments yet. Leave a Comment

Leave a Comment

Line and paragraph breaks are automatic. Some HTML allowed: <a href="" title="">, <b>, <i>, <strike>

Explore Rare Diseases
About.com Special Features

8 Ways to Cut Drug Costs

Learn how to save money on medications with these recommendations. More >

Healthy Bodies, Healthy Minds

Keep yourself, and your family, happy and healthy this season. More >

  1. Home
  2. Health
  3. Rare Diseases

©2010 About.com, a part of The New York Times Company.

All rights reserved.